FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $298,000 | -9.7% | 13,300 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $330,000 | -36.0% | 13,300 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $516,000 | -42.0% | 13,300 | -12.5% | 0.00% | -25.0% |
| Q4 2021 | $889,000 | -1.3% | 15,200 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $901,000 | -31.7% | 15,200 | 0.0% | 0.01% | -28.6% |
| Q2 2021 | $1,319,000 | +19.4% | 15,200 | +13.4% | 0.01% | +16.7% |
| Q1 2021 | $1,105,000 | -9.3% | 13,400 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $1,218,000 | +127.2% | 13,400 | 0.0% | 0.01% | +75.0% |
| Q3 2020 | $536,000 | -25.6% | 13,400 | -36.2% | 0.00% | +33.3% |
| Q2 2020 | $720,000 | – | 21,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
| Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
| Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
| Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
| Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
| Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
| DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
| Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
| Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |